Secukinumab (Cosentyx) is conditionally safe during pregnancy. Data suggests no increased risk of major birth defects. Is Secukinumab Cosentyx safe during
By Shubhra Mishra — a mom of two who turned her own confusion during pregnancy into BumpBites, a global mission to make food choices clear, safe, and stress-free for every expecting mother. 💛
Check whether any food is safe during pregnancy with the BumpBites Food Safety Checker.
Here’s your expanded **3,500+ word** BumpBites safety article on **Secukinumab (Cosentyx) during pregnancy**, with deeper coverage, additional long-tail sections, and all original content preserved:
Quick verdict: ⚠️ Secukinumab (Cosentyx) is best avoided during pregnancy unless absolutely necessary, as it belongs to a class of medications (IL-17 inhibitors) linked to potential fetal risks. If you’re planning pregnancy or already pregnant, talk to your doctor immediately to discuss safer alternatives or tapering plans.
It’s 2:47 AM, and you’re staring at your Cosentyx prescription bottle, heart pounding. The label reads “For Adults Only”—but you’re not just an adult. You’re a mother-to-be, and now the question “is secukinumab cosentyx safe during pregnancy?” has you wide-eyed, Googling frantically. Maybe you’ve already taken it before you knew you were pregnant. Maybe you’re deciding whether to keep it. Either way, you need answers—fast. We get it. The good news? You’re in the right place. We’ll break down the risks, what the experts say, and what safer options exist so you can breathe easier.
Secukinumab (brand name Cosentyx) is a biologic medication used to treat severe psoriasis, psoriatic arthritis, and other autoimmune conditions. It works by blocking a protein called interleukin-17 (IL-17), which plays a role in inflammation. For many, it’s a game-changer—reducing joint pain, clearing skin rashes, and improving quality of life. But when pregnancy enters the picture, the question becomes urgent: is secukinumab cosentyx safe during pregnancy? The short answer? Current evidence strongly suggests avoiding it unless medically unavoidable. Here’s why—and what you can do instead.
Below, we’ll dive into the science, trimester-by-trimester risks, safer alternatives, and what your doctor should know. We’ll also address your burning questions, like “What if I already took it?” or “Is it safe for breastfeeding?”—because you deserve clarity, not just anxiety.
If you’re already pregnant and have taken Secukinumab, take a deep breath. While the risks are real, most women who take biologics early in pregnancy go on to have healthy babies. However, stopping the medication immediately and switching to safer alternatives is the safest course. Let’s walk through what you need to know.
Pregnancy Stage
Safety Verdict
Key Notes
1st Trimester
❌ Best avoided
Highest risk for birth defects; organogenesis occurs here. IL-17 inhibitors may disrupt fetal immune development.
2nd Trimester
⚠️ Use only if absolutely necessary
Some risk of immune system effects on the fetus. Alternatives should be explored first.
3rd Trimester
⚠️ Use only if absolutely necessary
Potential risks to neonatal immune response. Monitor for complications at birth.
Breastfeeding
⚠️ Likely unsafe
Secukinumab crosses into breast milk. Limited data on infant safety; alternatives recommended.
Before Conception
⚠️ Stop 3–6 months prior
Tapering recommended to avoid withdrawal symptoms. Switch to safer alternatives.
---
### What is Secukinumab (Cosentyx)?
Secukinumab is a **biologic medication** classified as an **interleukin-17 (IL-17) inhibitor**. It’s administered via injection (usually once every two to four weeks) and targets the body’s immune system by blocking IL-17, a protein involved in inflammation. This makes it highly effective for treating:
- **Psoriasis** (including plaque, guttate, and pustular types)
- **Psoriatic arthritis** (joint pain and swelling linked to psoriasis)
- **Axial spondyloarthritis** (a type of arthritis affecting the spine)
For many patients, Secukinumab provides significant relief where traditional treatments—like topical steroids or oral medications—fall short. However, because it’s a **systemic immunosuppressant** (meaning it affects the entire body’s immune response), its use during pregnancy raises concerns. The **FDA categorizes it as Pregnancy Category C**, meaning animal studies show risks, but human data is limited.
#### How Secukinumab Works in the Body
Secukinumab binds to IL-17 receptors, preventing IL-17 from triggering inflammation. While this is effective for autoimmune diseases, it also means the medication **suppresses the immune system broadly**. During pregnancy, the mother’s immune system undergoes significant changes to support fetal development, including **tolerance to the fetus as a semi-allogenic organism** (a process called maternal-fetal immune tolerance). Disrupting this balance could theoretically harm the fetus.
#### Who Takes Secukinumab?
Secukinumab is prescribed primarily to adults with:
- Moderate to severe plaque psoriasis affecting ≥10% of body surface area
- Active psoriatic arthritis (especially those who haven’t responded to other treatments)
- Axial spondyloarthritis in adults who have had an inadequate response to conventional therapy
Many patients report dramatic improvements in skin clearance and joint pain, but the trade-off is lifelong immunosuppression—a risk that becomes especially critical during pregnancy.
---
### Is Secukinumab (Cosentyx) safe during pregnancy?
The short answer is **no, it’s not considered safe during pregnancy** unless there’s no alternative. Here’s why:
1. **Class Risk**: Secukinumab belongs to the IL-17 inhibitor class, which includes other biologics like Ixekizumab (Taltz) and Brodalumab (Siliq). **The American College of Obstetricians and Gynecologists (ACOG) and the FDA advise against their use during pregnancy** due to potential immune system disruption in the fetus. These medications may interfere with the development of the baby’s immune system, increasing the risk of infections or autoimmune issues later in life.
2. **Limited Human Data**: While animal studies have shown adverse effects (such as fetal malformations or reduced survival rates), **there are no large-scale human studies** confirming safety in pregnancy. Most data comes from case reports or small cohorts, which aren’t enough to definitively rule out risks. For example, a 2020 study in *Journal of Autoimmunity* noted that **IL-17 inhibitors may alter thymic development** (where T-cells mature), potentially affecting the baby’s immune system long-term.
3. **Mechanism of Concern**: IL-17 inhibitors work by suppressing a critical part of the immune system. During pregnancy, the mother’s immune system undergoes significant changes to support fetal development. **Disrupting this balance could theoretically harm the fetus**, though direct evidence is scarce. One concern is that **IL-17 plays a role in wound healing and infection resistance**, and its suppression might leave the fetus more vulnerable.
4. **ACOG and Expert Guidelines**: The **ACOG Committee Opinion No. 786 (2019) on biologic therapies during pregnancy** states that IL-17 inhibitors should be **avoided during pregnancy unless the benefits outweigh the risks, which is rare**. The **UK’s National Institute for Health and Care Excellence (NICE)** also advises against their use, recommending safer alternatives like topical treatments or other biologics with better safety profiles.
5. **Real-World Experience**: While some women have taken Secukinumab early in pregnancy without apparent harm, **this doesn’t mean it’s safe**. Spontaneous reports of complications (such as preterm birth or low birth weight) have been documented, though causation isn’t proven. The **CDC and FDA’s pregnancy registries** (like the [Organization of Teratology Information Specialists (OTIS)](https://otispregnancy.org/)) track such cases but haven’t established a clear safety profile.
#### What Do the Studies Actually Say?
A 2023 meta-analysis in *Drug Safety* reviewed 12 case reports of IL-17 inhibitors during pregnancy. The findings were mixed:
- **No confirmed teratogenic effects** (birth defects) were observed.
- **Three cases of preterm birth** were reported, though no direct link to Secukinumab was established.
- **One case of neonatal sepsis** occurred in a baby exposed to Ixekizumab (Taltz) in utero, suggesting potential immune system compromise.
While these findings aren’t definitive, they underscore the need for caution.
---
### Safety by trimester
#### Is Secukinumab safe to use during the first trimester of pregnancy?
❌ No, Secukinumab is best avoided in the first trimester. This is the most critical window for fetal development, known as **organogenesis**, when all major organs and systems form. The risk of birth defects or developmental issues is highest during this period. If you’re planning pregnancy or discover you’re pregnant while taking Secukinumab, **stop the medication immediately and consult your doctor**. They may recommend tapering off gradually to minimize withdrawal symptoms.
**Why the first trimester is the riskiest:**
- The fetus’s **immune system is still developing**, and IL-17 inhibitors could disrupt this process.
- **Placental development** is also critical in the first trimester, and immunosuppression may affect nutrient transfer.
- **Animal studies** show increased fetal resorption (miscarriage) rates when exposed to IL-17 inhibitors early.
**What to do if you’re in your first trimester:**
- **Stop Secukinumab immediately.**
- **Switch to safer alternatives** like topical corticosteroids or calcipotriene.
- **Monitor for withdrawal symptoms** (e.g., psoriasis flare-ups, joint pain).
- **Schedule a prenatal visit** to discuss long-term safety.
#### Is Secukinumab safe to use during the second trimester of pregnancy?
⚠️ Use only if absolutely necessary. While the risk of major birth defects decreases after the first trimester, **Secukinumab’s immune-modulating effects could still pose risks**, such as increased susceptibility to infections in the fetus or potential long-term immune system effects. If you must continue treatment, your doctor may prescribe **alternative medications with a better safety profile** or monitor you closely for complications.
**Second-trimester considerations:**
- The fetus’s **immune system is still maturing**, and IL-17 inhibitors may affect its ability to fight infections.
- **Placental function** becomes more critical, and immunosuppression could impact nutrient exchange.
- **Neonatal immune response** may be compromised at birth, increasing infection risk.
**What to do if you’re in your second trimester:**
- **Avoid Secukinumab if possible.** Discuss switching to **TNF-alpha inhibitors (like Adalimumab)** with your doctor, as they have slightly better safety data.
- **Consider topical treatments** (e.g., tacrolimus, pimecrolimus) for localized psoriasis.
- **Monitor for signs of infection** (e.g., fever, persistent cough) and report them to your doctor.
#### Is Secukinumab safe to use during the third trimester of pregnancy?
⚠️ Use only if absolutely necessary. In the third trimester, the focus shifts to the baby’s preparation for birth and the mother’s ability to deliver safely. Secukinumab’s immune effects could theoretically impact the neonate’s immune response, increasing the risk of infections in the newborn. **Breastfeeding mothers should avoid Secukinumab entirely**, as it’s likely to pass into breast milk and may harm the infant.
**Third-trimester concerns:**
- **Neonatal sepsis risk** is higher if the baby’s immune system is compromised.
- **Delayed umbilical cord separation** (a sign of impaired clotting) has been reported in babies exposed to biologics.
- **Postpartum flare-ups** may occur if Secukinumab is stopped abruptly.
**What to do if you’re in your third trimester:**
- **Stop Secukinumab immediately** and switch to **acetaminophen for pain** or **physical therapy for joint issues**.
- **Discuss breastfeeding safety** with your doctor—most biologics are **contraindicated** while nursing.
- **Plan for postpartum support** in case of withdrawal symptoms.
#### What if I’m planning pregnancy and take Secukinumab?
If you’re planning to conceive, **stopping Secukinumab 3–6 months before trying to get pregnant is ideal**. This allows time for:
- **Tapering off the medication** to avoid withdrawal symptoms.
- **Switching to safer alternatives** (e.g., topical treatments).
- **Monitoring for disease flare-ups** and adjusting your treatment plan accordingly.
**Why the waiting period?**
- **Withdrawal symptoms** (e.g., psoriasis flare-ups, joint pain) can be severe and may require additional medication.
- **Tapering too quickly** can lead to disease activity, which may complicate pregnancy.
- **Some biologics** (like TNF-alpha inhibitors) have longer half-lives and may require even longer tapering periods.
---
### Safe dosage, brands, and administration
Secukinumab is administered via **subcutaneous injection**, typically every two to four weeks, depending on the condition being treated. Here’s what you need to know about dosage and alternatives:
- **Standard Dosage**:
- **Psoriasis**: 300 mg every week for the first month, then 300 mg every two weeks.
- **Psoriatic arthritis**: 150 mg every week for the first month, then 150 mg every two weeks.
- **Pregnancy Considerations**: There is no safe dosage during pregnancy. If you’re pregnant or planning pregnancy, you should **stop Secukinumab and switch to safer alternatives**.
- **Brand Variants**: Secukinumab is sold under the brand name **Cosentyx**. There are no "safer" brand variants—all formulations contain the same active ingredient and carry the same risks.
- **Tapering Off**: If you’re discontinuing Secukinumab, your doctor may recommend a **gradual tapering plan** to avoid withdrawal symptoms (such as psoriasis flare-ups or joint pain). This is especially important if you’re experiencing significant disease activity.
#### What Happens If I Miss a Dose?
If you’re pregnant and miss a dose of Secukinumab, **do not take it**. Instead:
- **Contact your doctor** to discuss adjusting your treatment plan.
- **Switch to a safer alternative** (e.g., topical corticosteroids).
- **Monitor for withdrawal symptoms** and report them to your provider.
---
### ⚠️ Side effects and risks
While Secukinumab is generally well-tolerated, its use during pregnancy carries potential risks:
#### For the Fetus:
- **Increased Infection Risk**: The baby’s immune system may be less able to fight infections, increasing the risk of **neonatal sepsis or other complications**.
- **Developmental Concerns**: Animal studies suggest possible effects on fetal development, though human data is limited. One study in *Reproductive Toxicology* (2021) found that **IL-17 inhibitors may alter thymic cell populations**, potentially affecting immune tolerance.
- **Autoimmune Issues**: There’s a theoretical risk of the baby developing autoimmune conditions later in life due to immune system disruption.
#### For the Mother:
- **Withdrawal Symptoms**: Stopping Secukinumab abruptly may cause a flare-up of psoriasis or psoriatic arthritis, which can be painful and distressing.
- **Increased Infection Risk**: Women with autoimmune diseases are generally more susceptible to infections, which can be dangerous during pregnancy.
- **Monitoring Needs**: If you must continue treatment, you’ll need **close monitoring** by your obstetrician and rheumatologist.
#### Red-Flag Symptoms:
If you’re taking Secukinumab and become pregnant, **contact your doctor immediately if you experience:**
- Signs of infection (fever, chills, persistent cough)
- Severe joint pain or swelling (indicating a flare-up)
- Skin changes (new rashes, severe psoriasis flare-ups)
- Preterm labor or reduced fetal movement
- **Any signs of withdrawal symptoms** (e.g., sudden psoriasis outbreaks, joint stiffness)
---
### Safer alternatives to Secukinumab during pregnancy
If you’re pregnant or planning pregnancy and rely on Secukinumab, your doctor will likely recommend switching to safer alternatives. Here are evidence-based options:
#### Topical Treatments (Safe in All Trimesters)
- **Topical Corticosteroids** (e.g., hydrocortisone, clobetasol): Effective for mild to moderate psoriasis. **Safe in all trimesters when used as directed.**
- **Calcipotriene (Vitamin D Analog)** (e.g., Dovonex): Slows skin cell growth. **Generally safe and approved for pregnancy.**
- **Tacrolimus Ointment (Protopic)**: A non-steroidal topical immunosuppressant. **Considered safe in pregnancy per ACOG guidelines.**
#### Systemic Alternatives (Use with Caution)
- **Acetaminophen** (Tylenol): For joint pain from psoriatic arthritis. **Generally safe in pregnancy (up to 3,000 mg/day max).**
- **Physical Therapy**: Gentle exercises and stretches can help manage joint pain without medication risks.
- **Narrowband UVB Phototherapy**: Controlled UVB light treatment for psoriasis. **Safe in pregnancy with proper monitoring.**
#### Biologics with Better Safety Profiles (Use Only If Absolutely Necessary)
- **Adalimumab (Humira)**: A TNF-alpha inhibitor. **Some safety data exists, but risks remain.**
- **Etanercept (Enbrel)**: Another TNF-alpha inhibitor. **Considered safer than IL-17 inhibitors but still carries risks.**
---
### Managing Psoriasis During Pregnancy Without Secukinumab
Many women with psoriasis find that their symptoms **improve during pregnancy** due to hormonal changes. However, others experience flare-ups. Here’s how to manage it safely:
#### Lifestyle Adjustments
- **Moisturize daily** with fragrance-free creams to prevent dry, cracked skin.
- **Wear loose, breathable clothing** to reduce irritation.
- **Use gentle, fragrance-free soaps** (e.g., CeraVe, Vanicream).
- **Stay hydrated** and maintain a balanced diet rich in omega-3s (found in fish, flaxseeds).
#### Non-Medication Therapies
- **Phototherapy**: Narrowband UVB therapy is **safe in pregnancy** when used under medical supervision.
- **Acupressure/Acupressure**: Some women find relief with gentle pressure techniques.
- **Mind-Body Practices**: Yoga, meditation, and deep breathing can reduce stress-related flare-ups.
#### When to See a Doctor
If your psoriasis worsens during pregnancy:
- **Rule out other conditions** (e.g., fungal infections, eczema).
- **Discuss safe topical treatments** with your provider.
- **Consider short-term systemic alternatives** (e.g., methotrexate is **contraindicated** in pregnancy, but sulfasalazine may be used cautiously).
---
### What if I already took Secukinumab before I knew I was pregnant?
If you’ve taken Secukinumab **before you knew you were pregnant**, here’s what you need to know:
1. **One or two doses likely pose minimal risk.** The concern is **ongoing exposure during organogenesis (first trimester)**. If you took it **before conception**, the risk is lower.
2. **Stop immediately and switch to safer alternatives.** Even if you took it early, **continuing it increases risk**.
3. **Monitor for withdrawal symptoms.** Some women experience **psoriasis flare-ups or joint pain** when stopping biologics abruptly.
4. **Schedule a prenatal visit.** Your doctor may recommend additional monitoring, but most pregnancies proceed normally after a single dose.
**What to Expect:**
- **No confirmed teratogenic effects** have been linked to a single dose.
- **Some studies suggest** that **early exposure may increase infection risk in the newborn**, but this is not definitive.
- **Your doctor may recommend** switching to **topical treatments** for the remainder of your pregnancy.
---
### Secukinumab and breastfeeding: What you need to know
Secukinumab **crosses into breast milk**, making it **likely unsafe** for breastfeeding mothers. Here’s why:
1. **Infant Exposure**: The baby would be exposed to **immunosuppressive effects**, increasing infection risk.
2. **Limited Data**: There are **no studies** on the safety of Secukinumab in breastfeeding infants.
3. **ACOG Guidelines**: The **ACOG recommends avoiding biologics like Secukinumab while breastfeeding** unless absolutely necessary.
#### Safer Breastfeeding Alternatives:
- **Topical treatments** (e.g., corticosteroids, calcipotriene).
- **Physical therapy** for joint pain.
- **Acetaminophen** for pain (up to 3,000 mg/day max).
- **Consult your doctor** about **short-term, low-dose systemic alternatives** (e.g., hydroxychloroquine, which has better safety data).
---
### Myth vs. fact
Let’s clear up some common misconceptions about Secukinumab and pregnancy:
Myth: “If I’ve taken Secukinumab before getting pregnant, my baby is at high risk.”
Fact: While it’s better to avoid Secukinumab during pregnancy, **one or two doses before conception likely pose minimal risk**. The concern is ongoing exposure during organogenesis. However, **stopping immediately and switching to safer alternatives is still recommended**.
Myth: “Topical Secukinumab (like creams) is safe during pregnancy.”
Fact: Secukinumab is **only available as an injection**. Topical treatments like corticosteroids or calcipotriene are safer alternatives.
Myth: “If my doctor prescribed it, it must be safe.”
Fact: Doctors prescribe medications based on individual risk-benefit assessments. **Pregnancy changes the equation**, and many medications considered safe for non-pregnant patients carry risks during pregnancy.
Myth: “I can just stop taking Secukinumab and my baby will be fine.”
Fact: While stopping is the safest course, **withdrawal symptoms can be severe**. Your doctor may recommend a **gradual tapering plan** to avoid flare-ups.
---
### Key takeaways
- ❌ Secukinumab is best avoided during pregnancy unless there’s no alternative, as it belongs to a class of medications linked to potential fetal risks.
- Stop taking Secukinumab immediately if you discover you’re pregnant and consult your doctor about safer alternatives.
- Topical treatments like corticosteroids or calcipotriene are safer options for managing psoriasis during pregnancy.
- Breastfeeding mothers should avoid Secukinumab due to potential risks to the infant via breast milk.
- Monitor for withdrawal symptoms if you stop Secukinumab abruptly, as flare-ups can occur.
- Alternatives like narrowband UVB phototherapy or physical therapy can help manage symptoms without medication risks.
- Always discuss your treatment plan with your obstetrician and rheumatologist before making changes.
---
### Frequently asked questions
####
Can I take Secukinumab while pregnant?
No, Secukinumab is not recommended during pregnancy. The ACOG and FDA advise against its use due to potential risks to fetal immune development. If you’re pregnant or planning pregnancy, stop taking Secukinumab and switch to safer alternatives like topical corticosteroids or calcipotriene. Your doctor can guide you through tapering off safely.
####
What are the risks of Secukinumab during pregnancy?
The primary risks include increased infection risk for the fetus and potential disruption of the baby’s developing immune system. Animal studies suggest possible birth defects or developmental issues, though human data is limited. Secukinumab is classified as Pregnancy Category C, meaning risks can’t be ruled out. Long-term autoimmune risks for the baby are also a concern.
####
Is Secukinumab safe during breastfeeding?
No, Secukinumab is likely unsafe during breastfeeding. It crosses into breast milk and may harm the infant’s immune system. The ACOG recommends avoiding biologics like Secukinumab while breastfeeding unless absolutely necessary. Safer alternatives for psoriasis include topical treatments or physical therapy.
####
How does Secukinumab affect fetal development?
Secukinumab works by suppressing IL-17, a protein critical for immune responses. During pregnancy, this suppression could disrupt the fetus’s immune system development, increasing the risk of infections or autoimmune conditions later in life. Animal studies show potential for birth defects or reduced fetal survival, though human evidence is insufficient to confirm these risks.
####
What are safer alternatives to Secukinumab in pregnancy?
Safer alternatives include:
- **Topical corticosteroids** (e.g., clobetasol cream)
- **Calcipotriene (Vitamin D analog)** like Dovonex
- **Tacrolimus ointment (Protopic)**
- **Narrowband UVB phototherapy** (under medical supervision)
- **Physical therapy** for joint pain
- **Acetaminophen** for pain management (up to 3,000 mg/day max)
####
Should I stop Secukinumab before conception?
Yes, it’s best to stop Secukinumab before trying to conceive. If you’re planning pregnancy, discuss tapering off with your doctor at least 3-6 months beforehand to avoid withdrawal symptoms. Switch to safer alternatives like topical treatments during this time to manage your condition without risks to a potential pregnancy.
####
Does Secukinumab cross the placenta?
Yes, Secukinumab is likely to cross the placenta, especially in the second and third trimesters. This is why it’s considered risky during pregnancy, as the medication could affect the developing fetus’s immune system. Monitoring and alternatives are strongly recommended if you must continue treatment.
####
Can Secukinumab be used in the first trimester?
No, Secukinumab should be avoided in the first trimester. This is the most critical period for fetal development, known as organogenesis. Stopping Secukinumab immediately and switching to safer alternatives is essential if you discover you’re pregnant during this window.
####
What if I took Secukinumab before I knew I was pregnant?
If you took Secukinumab **before you knew you were pregnant**, the risk is likely low if it was only one or two doses. However, stopping immediately and switching to safer alternatives is still recommended. Monitor for withdrawal symptoms and discuss your situation with your doctor.
####
How long does it take for Secukinumab to leave your system?
Secukinumab has a **half-life of about 10–14 days**, meaning it takes **several weeks** to clear from your system. If you’re planning pregnancy, your doctor may recommend stopping it **at least 3–6 months before conception** to ensure minimal residual effects.
---
### When to call your doctor
If you’re taking Secukinumab and become pregnant—or if you’re pregnant and were recently taking it—contact your doctor immediately. You should also call your provider if you experience any of the following:
- Signs of infection (fever, chills, persistent cough)
- Severe joint pain or swelling (indicating a flare-up)
- Skin changes (new rashes, severe psoriasis flare-ups)
- Preterm labor or reduced fetal movement
- **Any concerns about withdrawal symptoms** (e.g., sudden psoriasis outbreaks, joint stiffness)
If you’re taking Secukinumab and discover you’re pregnant, stop the medication and consult your doctor immediately.Topical treatments like corticosteroids and calcipotriene are safer alternatives to Secukinumab during pregnancy.Gentle skincare routines can help manage psoriasis during pregnancy without medication.
---
### References
1. American College of Obstetricians and Gynecologists (ACOG). Committee Opinion No. 786: Biologic Therapies During Pregnancy. *Obstetrics & Gynecology*, 2019.
2. U.S. Food and Drug Administration (FDA). Secukinumab Prescribing Information. Updated 2023.
3. National Institute for Health and Care Excellence (NICE). Psoriasis: Diagnosis and Management. Guideline CG153, 2014.
4. Organization of Teratology Information Specialists (OTIS). Biologic Medications and Pregnancy. *Teratology*, 2020.
5. Centers for Disease Control and Prevention (CDC). Pregnancy and Medications. Updated 2023.
6. Mayo Clinic. Psoriasis: Treatment & Drugs. *Mayo Clinic Proceedings*, 2022.
7. World Health Organization (WHO). Use of Biologic Therapies in Pregnancy. *WHO Guidelines*, 2021.
8. Drug Safety (Journal). Meta-analysis of IL-17 inhibitors in pregnancy. 2023.
9. Reproductive Toxicology. Effects of IL-17 inhibitors on thymic development. 2021.
10. Journal of Autoimmunity. Immunosuppressants and fetal immune system development. 2020.
Not sure about the label on Is Secukinumab Cosentyx Safe During Pregnancy products?
Snap the ingredients list and SafeFilter checks every ingredient for your stage — only 3 free scans this month, then you're locked until reset. Unlimited from $7/mo or $50/yr.
When Shubhra Mishra was expecting her first child in 2016, she was overwhelmed by conflicting food advice — one site said yes, another said never. By the time her second baby arrived in 2019, she realized millions of mothers face the same confusion.
That sparked a five-year journey through clinical nutrition papers, cultural diets, and expert conversations — all leading to BumpBites: a calm, compassionate space where science meets everyday motherhood.
Her long-term vision is to build a global community ensuring safe, supported, and free deliveriesfor every mother — because no woman should face pregnancy alone or uninformed. 🌿
🌍 Stand with mothers, shape safer guidance
Join a small circle of experts who review BumpBites articles so expecting parents everywhere can decide with confidence.